Terms: = Prostate cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB
1196 results:
1. Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors.
Gupta V; Vashisht V; Vashisht A; Mondal AK; Alptekin A; Singh H; Kolhe R
Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674331
[TBL] [Abstract] [Full Text] [Related]
2. DB-1310, an ADC comprised of a novel anti-HER3 antibody conjugated to a DNA topoisomerase I inhibitor, is highly effective for the treatment of HER3-positive solid tumors.
Li X; Yao J; Qu C; Luo L; Li B; Zhang Y; Zhu Z; Qiu Y; Hua H
J Transl Med; 2024 Apr; 22(1):362. PubMed ID: 38632563
[TBL] [Abstract] [Full Text] [Related]
3. Chlordiazepoxide against signalling, receptor and regulatory proteins of breast cancer: a structure-based in-silico approach.
Alsaiari AA; Gharib AF; Bakhuraysah MM; Alrehaili AA; Algethami SM; Alsaif HA; Al Harthi N; Hakami MA
Med Oncol; 2024 Apr; 41(5):117. PubMed ID: 38630325
[TBL] [Abstract] [Full Text] [Related]
4. Clinical safety and efficacy of microwave ablation for small renal masses.
Foret A; Haaga CB; Jain S; Baumgartner CO; Escott M; Henderson BR; O'Brien ST; Delacroix SE; Gills JRR; Westerman ME
Int Braz J Urol; 2024; 50(3):277-286. PubMed ID: 38598830
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic microRNAs as biomarkers for prostate cancer.
Palanisamy H; Manoharan JP; Vidyalakshmi S
J Cancer Res Ther; 2024 Jan; 20(1):297-303. PubMed ID: 38554337
[TBL] [Abstract] [Full Text] [Related]
6. Microbiome Dysbiosis Is Associated with Castration Resistance and cancer Stemness in Metastatic prostate cancer.
Uzelac M; Xin R; Ongkeko WM
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542265
[TBL] [Abstract] [Full Text] [Related]
7. Network pharmacology and experimental evaluation strategies to decipher the underlying pharmacological mechanism of Traditional Chinese Medicine CFF-1 against prostate cancer.
Wei Y; Zhu M; Chen Y; Ji Q; Wang J; Shen L; Yang X; Hu H; Zhou X; Zhu Q
Aging (Albany NY); 2024 Mar; 16(6):5387-5411. PubMed ID: 38484140
[TBL] [Abstract] [Full Text] [Related]
8. Development of certain benzylidene coumarin derivatives as anti-prostate cancer agents targeting egfr and PI3Kβ kinases.
Elagawany M; Abdel Ghany LMA; Ibrahim TS; Alharbi AS; Abdel-Aziz MS; El-Labbad EM; Ryad N
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2311157. PubMed ID: 38348846
[TBL] [Abstract] [Full Text] [Related]
9. The role of polyethylenimine-functionalized gold nanoclusters carrying plasmid CMTM5 in impeding the malignant progression of prostate cancer cells by promoting egfr endocytosis.
Li L; Li C; Miao F; Chen W; Kong X; Ye R; Feng R
Neoplasma; 2024 Feb; 71(1):48-59. PubMed ID: 38295104
[TBL] [Abstract] [Full Text] [Related]
10. Association of estimated glomerular filtration rate with prostate cancer risk in a cross-ethnic population: a Mendelian randomization study.
Zhang H; Li T; Jia Y
BMC Urol; 2024 Jan; 24(1):18. PubMed ID: 38263127
[TBL] [Abstract] [Full Text] [Related]
11. An Efficient Synthesis of 1-(1,3-Dioxoisoindolin-2-yl)-3-aryl Urea Analogs as Anticancer and Antioxidant Agents: An Insight into Experimental and
Afzal O; Ahsan MJ
Molecules; 2023 Dec; 29(1):. PubMed ID: 38202650
[TBL] [Abstract] [Full Text] [Related]
12. Delivery of gefitinib loaded nanoparticles for effectively inhibiting prostate cancer progression.
Xiong Z; Tong T; Xie Z; Yu S; Zhuang R; Jia Q; Peng S; Li B; Xie J; Li K; Wu J; Huang H
Biomater Sci; 2024 Jan; 12(3):650-659. PubMed ID: 38168678
[TBL] [Abstract] [Full Text] [Related]
13. Metastatic Lymph Node 64 (MLN64) Expression in Gastric cancer: The Clinical and Molecular Implications in Drug Resistance.
Li AX; Zeng JJ; Khan E; Dou QP; Zhuang X; Ji EK; Ruge F; Martin TA; Jia S; Jiang WG
Cancer Genomics Proteomics; 2024; 21(1):30-40. PubMed ID: 38151289
[TBL] [Abstract] [Full Text] [Related]
14. Antitumor Activity and Mechanism of Terpenoids in Seaweeds Based on Literature Review and Network Pharmacology.
Chen B; Li Y; Li W; Ye S; Zhu L; Ding Y
Adv Biol (Weinh); 2024 Mar; 8(3):e2300541. PubMed ID: 38134388
[TBL] [Abstract] [Full Text] [Related]
15. Computational Design, Synthesis, and Bioevaluation of 2-(Pyrimidin-4-yl)oxazole-4-carboxamide Derivatives: Dual Inhibition of egfr
Raghunath Khedkar N; Sindkhedkar M; Joseph A
Bioorg Chem; 2024 Feb; 143():107027. PubMed ID: 38096682
[TBL] [Abstract] [Full Text] [Related]
16. Determinants of Bone-Modifying Agent Prescribing for Metastatic Castration-Resistant prostate cancer in a National Health Care Delivery System.
Nguyen CB; Kobe C; Kumbier KE; Bauman J; Burns JA; Tsao PA; Sparks JB; Skolarus TA; Caram MEV
JCO Oncol Pract; 2024 Jan; 20(1):59-68. PubMed ID: 38085028
[TBL] [Abstract] [Full Text] [Related]
17. CAV1 and KRT5 are potential targets for prostate cancer.
Guo L; Liu Y; Yang T; Wang G; Liu J; Li S; Liu B; Cai J
Medicine (Baltimore); 2023 Dec; 102(49):e36473. PubMed ID: 38065913
[TBL] [Abstract] [Full Text] [Related]
18. Associations between BMI in youth and site-specific cancer in men-A cohort study with register linkage.
Onerup A; Mehlig K; Af Geijerstam A; Ekblom-Bak E; Kuhn HG; Lissner L; Rosengren A; Börjesson M; Åberg M
Obesity (Silver Spring); 2024 Feb; 32(2):376-389. PubMed ID: 37927128
[TBL] [Abstract] [Full Text] [Related]
19. Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/egfr.
Kim S; Park JM; Park S; Jung E; Ko D; Park M; Seo J; Nam KD; Kang YK; Lee K; Farrand L; Kim YJ; Kim JY; Seo JH
J Exp Clin Cancer Res; 2023 Nov; 42(1):292. PubMed ID: 37924112
[TBL] [Abstract] [Full Text] [Related]
20. egfr-mediated hyperacetylation of tubulin induced docetaxel resistance by downregulation of HDAC6 and upregulation of MCAK and PLK1 in prostate cancer cells.
Pu YS; Huang CY; Wu HL; Wu JH; Su YF; Yu CR; Lu CY; Wu WJ; Huang SP; Huang YT; Hour TC
Kaohsiung J Med Sci; 2024 Jan; 40(1):23-34. PubMed ID: 37916740
[TBL] [Abstract] [Full Text] [Related]
[Next]
